Endocrine

, Volume 37, Issue 1, pp 106–114 | Cite as

11β-hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension

  • Carmen Campino
  • Cristian A. Carvajal
  • Javiera Cornejo
  • Betty San Martín
  • Oliviero Olivieri
  • Giancesare Guidi
  • Giovanni Faccini
  • Francesco Pasini
  • Javiera Sateler
  • Rene Baudrand
  • Lorena Mosso
  • Gareth I. Owen
  • Alexis M. Kalergis
  • Oslando Padilla
  • Carlos E. Fardella
Original Article

Abstract

Cortisol availability is modulated by several enzymes: 11β-HSD2, which transforms cortisol (F) to cortisone (E) and 11β-HSD1 which predominantly converts inactive E to active F. Additionally, the A-ring reductases (5α- and 5β-reductase) inactivate cortisol (together with 3α-HSD) to tetrahydrometabolites: 5αTHF, 5βTHF, and THE. The aim was to assess 11β-HSD2, 11β-HSD1, and 5β-reductase activity in hypertensive patients. Free urinary F, E, THF, and THE were measured by HPLC–MS/MS in 102 essential hypertensive patients and 18 normotensive controls. 11β-HSD2 enzyme activity was estimated by the F/E ratio, the activity of 11β-HSD1 in compare to 11β-HSD2 was inferred by the (5αTHF + 5βTHF)/THE ratio and 5β-reductase activity assessed using the E/THE ratio. Activity was considered altered when respective ratios exceeded the maximum value observed in the normotensive controls. A 15.7% of patients presented high F/E ratio suggesting a deficit of 11β-HSD2 activity. Of the remaining 86 hypertensive patients, two possessed high (5αTHF + 5βTHF)/THE ratios and 12.8% had high E/THE ratios. We observed a high percentage of alterations in cortisol metabolism at pre-receptor level in hypertensive patients, previously misclassified as essential. 11β-HSD2 and 5β-reductase decreased activity and imbalance of 11β-HSDs should be considered in the future management of hypertensive patients.

Keywords

Essential hypertension 11β-HSD2 11β-HSD1 5β-reductase 

Notes

Acknowledgments

The authors thank Mr. Yester Nuñez of the Laboratory of Pharmacology, Faculty of Veterinary Medicine, Universidad de Chile for his valuable assistance in the determination of cortisol and its metabolites by HPLC–MS/MS. This work was supported by Fondo Nacional de Investigación Científica y Tecnológica (Fondecyt) n° 1070876 and Millennium Nucleus on Immunology and Immunotherapy Grant P04/030-F.

References

  1. 1.
    F. Hammer, P.M. Stewart, Best Pract. Res. Clin. Endocrinol. Metab. 20, 337–353 (2006)CrossRefPubMedGoogle Scholar
  2. 2.
    P. Krall, L. Mosso, C. Carvajal, A. Rojas, C. Fardella, Rev. Med. Chile 132, 1053–1059 (2004)PubMedGoogle Scholar
  3. 3.
    A.L. Albiston, Mol. Cell. Endocrinol. 105, R11–R17 (1994)CrossRefPubMedGoogle Scholar
  4. 4.
    S. Zbánková, J. Bryndová, P. Leden, M. Kment, A. Svec, J. Pácha, J. Gastroenterol. Hepatol. 22, 1019–1023 (2007)CrossRefPubMedGoogle Scholar
  5. 5.
    J.W. Tomlinson, E.A. Walker, I.J. Bujalska, G.G. Lavery, M.S. Cooper, M. Hewison, P.M. Stewart, Endocr. Rev. 25, 831–866 (2004)CrossRefPubMedGoogle Scholar
  6. 6.
    N. Draper, P.M. Stewart, J. Endocrinol. 186, 251–271 (2005)CrossRefPubMedGoogle Scholar
  7. 7.
    J.W. Tomlinson, J. Finney, B.A. Hughes, S.V. Hughes, P.M. Stewart, Diabetes 57, 1536–1543 (2008)CrossRefPubMedGoogle Scholar
  8. 8.
    S. Ulick, L.S. Levine, P. Gunczler, G. Zanconato, L.C. Ramirez, W. Rauh, A. Rösler, H.L. Bradlow, J. Clin. Endocrinol. Metab. 49, 757–764 (1979)CrossRefPubMedGoogle Scholar
  9. 9.
    P.M. Stewart, J.E. Corrie, C.H. Shackleton, C.R. Edwards, J. Clin. Invest. 82, 340–349 (1988)CrossRefPubMedGoogle Scholar
  10. 10.
    C. Monder, C.H. Shackleton, H.L. Bradlow, M.I. New, E. Stoner, F. Iohan, V. Lakshmi, J. Clin. Endocrinol. Metab. 63, 550–557 (1986)CrossRefPubMedGoogle Scholar
  11. 11.
    G.C. Inglis, M.C. Ingram, C.D. Holloway, L. Swan, D. Birnie, W.S. Hillis, E. Davies, R. Fraser, J.M. Connell, J. Clin. Endocrinol. Metab. 84, 4132–4137 (1999)CrossRefPubMedGoogle Scholar
  12. 12.
    M.C. Ingram, A.M. Wallace, A. Collier, R. Fraser, J.M. Connell, Clin. Exp. Pharmacol. Physiol. 23, 375–378 (1996)CrossRefPubMedGoogle Scholar
  13. 13.
    R.M. Reynolds, B.R. Walker, H.E. Syddall, R. Andrew, P.J. Wood, C.B. Whorwood, D.I. Phillips, J. Clin. Endocrinol. Metab. 86, 245–250 (2001)CrossRefPubMedGoogle Scholar
  14. 14.
    R.M. Reynolds, B.R. Walker, D.I. Phillips, E.M. Dennison, R. Fraser, S.M. Mackenzie, E. Davies, J.M. Connell, Hypertension 53, 932–936 (2009)CrossRefPubMedGoogle Scholar
  15. 15.
    M.T. Epstein, E.A. Espiner, R.A. Donald, H. Hughes, R.J. Cowles, S. Lun, J. Clin. Endocrinol. Metab. 47, 397–400 (1978)CrossRefPubMedGoogle Scholar
  16. 16.
    M.A. Mackenzie, W.H. Hoefnagels, R.W. Jansen, T.J. Benraad, P.W. Kloppenborg, J. Clin. Endocrinol. Metab. 70, 1637–1643 (1990)CrossRefPubMedGoogle Scholar
  17. 17.
    Y. Kageyama, H. Suzuki, T. Saruta, J. Endocrinol. 135, 147–152 (1992)CrossRefPubMedGoogle Scholar
  18. 18.
    H.A. Sigurjonsdottir, K. Manhem, M. Axelson, S. Wallerstedt, J. Hum. Hypertens. 17, 125–131 (2003)CrossRefPubMedGoogle Scholar
  19. 19.
    J.A. Whitworth, P.M. Williamson, M.A. Brown, C.R. Edwards, Clin. Exp. Hypertens. 16, 431–450 (1994)CrossRefPubMedGoogle Scholar
  20. 20.
    T. Mune, F.M. Rogerson, H. Nikkila, A.K. Agarwal, P.C. White, Nat. Genet. 10, 394–399 (1995)CrossRefPubMedGoogle Scholar
  21. 21.
    R.C. Wilson, Z.S. Krozowski, K. Li, V.R. Obeyesekere, M. Razzaghy-azar, M.D. Harbison, J.Q. Wei, C.H. Shackleton, J.W. Funder, M.I. New, J. Clin. Endocrinol. Metab. 80, 2263–2266 (1995)CrossRefPubMedGoogle Scholar
  22. 22.
    C.A. Carvajal, A.A. Gonzalez, D. Romero, A. Gonzalez, L.M. Mosso, E.T. Lagos, M.d.P. Hevia, M.P. Rosati, T.O. Perez-Acle, C.E. Gomez-Sanchez, J.A. Montero, C.E. Fardella, J. Clin. Endocrinol. Metab. 88, 2501–2507 (2003)CrossRefPubMedGoogle Scholar
  23. 23.
    R.C. Wilson, S. Dave-Sharma, J.Q. Wei, V.R. Obeyesekere, K. Li, P. Ferrari, Z.S. Krozowski, C.H. Shackleton, L. Bradlow, T. Wiens, M.I. New, Proc. Natl Acad. Sci. USA 95, 10200–10205 (1998)CrossRefPubMedGoogle Scholar
  24. 24.
    C.A. Carvajal, D.G. Romero, L.M. Mosso, A.A. Gonzalez, C. Campino, J. Montero, C.E. Fardella, J. Hypertens. 23, 71–77 (2005)CrossRefPubMedGoogle Scholar
  25. 25.
    A.K. Agarwal, G. Giacchetti, G. Lavery, H. Nikkila, M. Palermo, M. Ricketts, C. McTernan, G. Bianchi, P. Manunta, P. Strazzulo, F. Mantero, P.C. White, P.M. Stewart, Hypertension 36, 187–194 (2000)PubMedGoogle Scholar
  26. 26.
    M.L. Ricketts, J.M. Verhaeg, I. Bujalska, A.J. Howie, W.E. Rainey, P.M. Stewart, J. Clin. Endocrinol. Metab. 83, 1325–1335 (1998)CrossRefPubMedGoogle Scholar
  27. 27.
    B.R. Walker, J.L. Yau, L.P. Brett, J.R. Seckl, C. Monder, B.C. Williams, C.R. Edwards, Endocrinology 129, 3305–3312 (1991)CrossRefPubMedGoogle Scholar
  28. 28.
    P.W.F. Hadoke, C. Christy, Y.V. Kotelevtsev, B.C. Williams, C.J. Kenyon, J.R. Seckl, Circulation 104, 2832–2837 (2001)CrossRefPubMedGoogle Scholar
  29. 29.
    R. Baudrand, C.A. Carvajal, A. Riquelme, M. Morales, N. Solis, M. Pizarro, A. Escalona, C. Boza, G. Pérez, A. Domínguez, M. Arrese, C.E. Fardella, Obes. Surg. (2009) [Epub ahead of print]Google Scholar
  30. 30.
    P.W. Franks, W.C. Knowler, S. Nair, J. Koska, Y.H. Lee, R.S. Llindsay, B.R. Walker, H.C. Looker, P.A. Permana, P.A. Tataranni, R.L. Hanson, Hypertension 44, 681–688 (2004)CrossRefPubMedGoogle Scholar
  31. 31.
    H. Masuzaki, H. Yamamoto, C.J. Kenyon, J.K. Elmquist, N.M. Morton, J.M. Paterson, H. Shinyama, M.G. Sharp, S. Fleming, J.J. Mullins, J.R. Seckl, J.S. Flier, J. Clin. Invest. 112, 83–90 (2003)PubMedGoogle Scholar
  32. 32.
    J. Voigt, H. Köster, Biochem. Biophys. Acta 842, 100–107 (1985)PubMedGoogle Scholar
  33. 33.
    H. Masuzaki, J. Paterson, H. Shinyama, N.M. Morton, J.J. Mullins, J.R. Seckl, J.S. Flier, A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166–2170 (2001)CrossRefPubMedGoogle Scholar
  34. 34.
    J.M. Paterson, N.M. Morton, C. Fievet, C.J. Kenyon, M.C. Holmes, B. Staels, J.R. Seckl, J.J. Mullins, Proc. Natl Acad. Sci. USA 101, 7088–7093 (2004)CrossRefPubMedGoogle Scholar
  35. 35.
    P.M. Stewart, Eur. J. Endocrinol. 149, 163–168 (2003)CrossRefPubMedGoogle Scholar
  36. 36.
    R. Best, B.R. Walker, Clin. Endocrinol. (Oxford) 47, 231–236 (1997)CrossRefGoogle Scholar
  37. 37.
    M. Palermo, C.H. Schackleton, F. Mantero, P.M. Stewart, Clin. Endocrinol. (Oxford) 45, 605–611 (1996)CrossRefGoogle Scholar
  38. 38.
    M. Quinkler, D. Zehnder, J. Lepenies, M.D. Petrelli, J.S. Moore, S.V. Hughes, P. Cockwell, M. Hewison, P.M. Stewart, Eur. J. Endocrinol. 153, 291–299 (2005)CrossRefPubMedGoogle Scholar
  39. 39.
    J.W. Tomlinson, J. Finney, C. Gay, B.A. Hughes, S.V. Hughes, P.M. Stewart, Diabetes 57, 2652–2660 (2008)CrossRefPubMedGoogle Scholar
  40. 40.
    U. Turpeinen, H. Markkanen, T. Sane, E. Hämäläinen, Scand. J. Clin. Lab. Invest. 66, 147–160 (2006)CrossRefPubMedGoogle Scholar
  41. 41.
    U. Turpeinen, U.H. Stenman, Scand. J. Clin. Lab. Invest. 63, 143–150 (2003)PubMedGoogle Scholar
  42. 42.
    U. Turpeinen, H. Markkanen, M. Välimäki, U.H. Stenman, Clin. Chem. 43, 1386–1391 (1997)PubMedGoogle Scholar
  43. 43.
    J.G. Vieira, O.H. Nakamura, V.M. Carvalho, Arq. Bras. Endocrinol. Metabol. 49, 291–298 (2005)PubMedGoogle Scholar
  44. 44.
    J.M. Bland, D.G. Altman, Lancet 1, 307–310 (1986)PubMedGoogle Scholar
  45. 45.
    M.H. Choi, J.R. Hahm, B.H. Jung, B.C. Chung, Clin. Chim. Acta 320, 95–99 (2002)CrossRefPubMedGoogle Scholar
  46. 46.
    Y. Kasuya, H. Shibasaki, T. Furuta, Steroids 65, 89–97 (2000)CrossRefPubMedGoogle Scholar
  47. 47.
    A.A. Gonzalez, C.A. Carvajal, E. Riquelme, P. Krall, C.R. Munoz, L. Mosso, A.M. Kalergis, C.E. Fardella, Am. J. Hypertens. 20, 800–806 (2007)CrossRefPubMedGoogle Scholar
  48. 48.
    O. Melander, M. Orho-Melander, K. Bengtsson, U. Lindblad, L. Råstam, L. Groop, U.L. Hulthén, J. Hum. Hypertens. 14, 819–823 (2000)CrossRefPubMedGoogle Scholar
  49. 49.
    B. Mariniello, V. Ronconi, C. Sardu, A. Pagliericcio, F. Galletti, P. Strazzullo, M. Palermo, M. Boscaro, P.M. Stewart, F. Mantero, G. Giacchetti, Am. J. Hypertens. 18, 1091–1098 (2005)CrossRefPubMedGoogle Scholar
  50. 50.
    R. Alikhani-Koupaei, F. Fouladkou, P. Fustier, B. Cenni, A.M. Sharma, H.C. Deter, B.M. Frey, F.J. Frey, FASEB J. 21, 3618–3628 (2007)CrossRefPubMedGoogle Scholar
  51. 51.
    M.N. Morton, J.R. Seckl, Front. Horm. Res. 36, 146–164 (2008)CrossRefPubMedGoogle Scholar
  52. 52.
    G.G. Lavery, E.A. Walker, A. Tiganescu, J.P. Ride, C.H. Shackleton, J.W. Tomlinson, J.M. Connell, D.W. Ray, A. Biason-Lauber, E.M. Malunowicz, W. Arlt, P.M. Stewart, J. Clin. Endocrinol. Metab. 93, 3827–3832 (2008)CrossRefPubMedGoogle Scholar
  53. 53.
    B.R. Walker, R. Andrew, Ann. N. Y. Acad. Sci. 1083, 165–184 (2006)CrossRefPubMedGoogle Scholar
  54. 54.
    G. Wolf, Nutr. Rev. 60, 148–151 (2002)CrossRefPubMedGoogle Scholar
  55. 55.
    D.J. Morris, S.A. Latif, M.P. Hardy, A.S. Brem, J. Steroid Biochem. Mol. Biol. 104, 161–168 (2007)CrossRefPubMedGoogle Scholar
  56. 56.
    K. Iki, I. Miyamori, H. Hatakeyama, T. Yoneda, Y. Takeda, R. Takeda, Q. Dai, Steroids 59, 656–660 (1994)CrossRefPubMedGoogle Scholar
  57. 57.
    A. Soro, M.C. Ingram, G. Tonolo, N. Glorioso, R. Fraser, Hypertension 25, 67–70 (1995)PubMedGoogle Scholar
  58. 58.
    M.J. Finken, R.C. Andrews, R. Andrew, B.R. Walker, J. Clin. Endocrinol. Metab. 84, 3316–3321 (1999)CrossRefPubMedGoogle Scholar
  59. 59.
    A.G. Atanasov, A. Odermatt, Endocr. Metab. Immune Disord. Drug Targets 7, 125–140 (2007)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Carmen Campino
    • 1
  • Cristian A. Carvajal
    • 1
  • Javiera Cornejo
    • 2
  • Betty San Martín
    • 2
  • Oliviero Olivieri
    • 3
  • Giancesare Guidi
    • 4
  • Giovanni Faccini
    • 4
  • Francesco Pasini
    • 3
  • Javiera Sateler
    • 5
  • Rene Baudrand
    • 1
  • Lorena Mosso
    • 1
  • Gareth I. Owen
    • 6
  • Alexis M. Kalergis
    • 7
  • Oslando Padilla
    • 8
  • Carlos E. Fardella
    • 1
  1. 1.Departamento de Endocrinología, Facultad de MedicinaPontificia Universidad Católica de ChileSantiagoChile
  2. 2.Laboratorio de FarmacologíaUniversidad de ChileSantiagoChile
  3. 3.Section of Internal Medicine, Department of Clinical and Experimental MedicineUniversity of VeronaVeronaItaly
  4. 4.Section of Clinical Chemistry, Department of Morphological and Biomedical SciencesUniversity of VeronaVeronaItaly
  5. 5.Departamento Medicina FamiliarPontificia Universidad Católica de ChileSantiagoChile
  6. 6.Departamento Ciencias FisiológicasPontificia Universidad Católica de ChileSantiagoChile
  7. 7.Departamento de Genética MolecularPontificia Universidad Católica de ChileSantiagoChile
  8. 8.Departamento Salud PúblicaPontificia Universidad Católica de ChileSantiagoChile

Personalised recommendations